Skip to main content

Developing Access to Liver Transplant Biospecimens

By June 2, 2021September 3rd, 2021No Comments

The MT Group is proud to announce it is onboarding a large academic transplant center that focuses on liver disease. This site handles hundreds of cases every year including those resulting from alcoholic cirrhosis, hepatocellular carcinoma, hepatitis cirrhosis, non-alcoholic fatty liver disease (NASH), and many other causes. If these biospecimens may be helpful to your research, please send us a message on this site.